Yahoo Finance • 26 days ago
[Blood collection tubes Mpox test positive results,WHO to rename monkeypox as ‘Mpox’] JUN LI The mpox outbreak that originated from Africa last year can no longer be considered a global emergency due to a sustained decline in cases and im... Full story
Yahoo Finance • 2 months ago
The following are today's upgrades for Validea's Small-Cap Growth Investor model based on the published strategy of Motley Fool. This strategy looks for small cap growth stocks with solid fundamentals and strong price performance. REX AME... Full story
Yahoo Finance • 2 months ago
Earnings Call Insights: SIGA Technologies, Inc. (SIGA) Q2 2025 MANAGEMENT VIEW * CEO Diem Nguyen highlighted that "SIGA continues to make steady progress as we advance our strategic initiatives. The evolving global landscape calls for... Full story
Yahoo Finance • 2 months ago
NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Generated Product Revenues of $79 million for the Three Months Ended June 30Awarded Additional Development Funding of $27 million under the BARDA 19C Contract during the Three Months Ended Jun... Full story
Yahoo Finance • 2 months ago
NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at... Full story
Yahoo Finance • 6 months ago
NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that its board of directors declared a special cash dividend of $0.60 per share on the... Full story
Yahoo Finance • 7 months ago
NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, announced today the appointment of Retired United States Army General John “Jack” Keane to its Board o... Full story
Yahoo Finance • 7 months ago
Increased Product Sales to $133 Million in 2024Generated Pre-tax Operating Income and Net Income of $70 Million and $59 Million, Respectively, in 2024Corporate Update Conference Call Today at 4:30 PM ET NEW YORK, March 11, 2025 (GLOBE N... Full story
Yahoo Finance • 7 months ago
NEW YORK, March 04, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update a... Full story
Yahoo Finance • 2 years ago
SIGA Technologies Inc. NEW YORK, Jan. 22, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Diem Nguyen, Ph.D., wi... Full story
Yahoo Finance • 2 years ago
- In Third Quarter, SIGA Received U.S. Government Orders for Approximately $113 Million of Oral TPOXX and $25 Million of IV TPOXX® - - In October, Joint Procurement Framework Contract was signed by European Commission with Anticipated Ini... Full story
Yahoo Finance • 2 years ago
NEW YORK, Oct. 26, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at... Full story
Yahoo Finance • 2 years ago
NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced the creation by the European Commission’s DG HERA... Full story
Yahoo Finance • 2 years ago
NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Jay K. Varma has joined SIGA as Executi... Full story
Yahoo Finance • 2 years ago
NEW YORK, June 27, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that SIGA CEO Phil Gomez, PhD, will present an ov... Full story
Yahoo Finance • 2 years ago
NEW YORK, May 04, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that the Board of Directors declared a special cash dividend of $0.45 per share on the c... Full story
Yahoo Finance • 2 years ago
NEW YORK, April 27, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update a... Full story
Yahoo Finance • 3 years ago
Participants Daniel J. Luckshire; Executive VP, CFO & Secretary; SIGA Technologies, Inc. Phillip Louis Gomez; CEO & Director; SIGA Technologies, Inc. Soo Romanoff; Analyst; Edison Investment Research Limited Presentation Operator Lad... Full story
Yahoo Finance • 3 years ago
- Approximately $71 Million of International Product Sales in 2022 - - Corporate Update Conference Call Today at 4:30 PM ET - NEW YORK, March 02, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stag... Full story
Yahoo Finance • 3 years ago
In this piece, we will take a look at 13 high growth pharma stocks that are profitable. For more stocks, head on over to 5 High Growth Pharma Stocks that are Profitable. One industry that has rapidly evolved with time and impacted million... Full story